Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thellung

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
BMC Veterinary Research|March 16, 2012
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axisAngelo Ferrari, Claudio Petterino, Alessandra Ratto, et al.
Pharmacological Research|September 27, 2016
Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharideValentina Villa, Stefano Thellung, Adriana Bajetto, et al.
The International Journal of Biochemistry & Cell Biology|November 25, 2010
High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion proteinAlessandro Corsaro, Stefano Thellung, Tonino Bucciarelli, et al.
Glia|August 21, 2007
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activationStefano Thellung, Valentina Villa, Alessandro Corsaro, et al.
Journal of Neuroscience Research|November 18, 1998
Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell lineT Florio, S Thellung, C Amico, et al.
Molecular Neurobiology|November 19, 2014
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial CellsValentina Villa, Stefano Thellung, Alessandro Corsaro, et al.
International Journal of Endocrinology|December 9, 2014
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 SystemFederica Barbieri, Stefano Thellung, Roberto Würth, et al.
European Journal of Endocrinology|October 20, 1999
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitroT Florio, S Thellung, S Arena, et al.
Experimental Cell Research|February 28, 2012
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potentialFederica Barbieri, Roberto Wurth, Alessandra Ratto, et al.
Neurotoxicity Research|April 23, 2009
Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231Alessandro Corsaro, Stefano Thellung, Katia Chiovitti, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
BMC Veterinary Research|March 16, 2012
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axisAngelo Ferrari, Claudio Petterino, Alessandra Ratto, et al.
Pharmacological Research|September 27, 2016
Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharideValentina Villa, Stefano Thellung, Adriana Bajetto, et al.
The International Journal of Biochemistry & Cell Biology|November 25, 2010
High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion proteinAlessandro Corsaro, Stefano Thellung, Tonino Bucciarelli, et al.
Glia|August 21, 2007
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activationStefano Thellung, Valentina Villa, Alessandro Corsaro, et al.
Journal of Neuroscience Research|November 18, 1998
Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell lineT Florio, S Thellung, C Amico, et al.
Molecular Neurobiology|November 19, 2014
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial CellsValentina Villa, Stefano Thellung, Alessandro Corsaro, et al.
International Journal of Endocrinology|December 9, 2014
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 SystemFederica Barbieri, Stefano Thellung, Roberto Würth, et al.
European Journal of Endocrinology|October 20, 1999
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitroT Florio, S Thellung, S Arena, et al.
Experimental Cell Research|February 28, 2012
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potentialFederica Barbieri, Roberto Wurth, Alessandra Ratto, et al.
Neurotoxicity Research|April 23, 2009
Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231Alessandro Corsaro, Stefano Thellung, Katia Chiovitti, et al.
Pageof 10